The US cardiology market is estimated to grow significantly at a CAGR of around 6.0% during the forecast period. The market is mainly due to the significant prevalence of CVD in the country.  The US has a high incidence & prevalence rate of heart diseases due to a sedentary lifestyle, excessive consumption of alcohol, consumption of junk food, high intake of cholesterol and a huge number of diabetic & obese patients. As a result, in the US alone, the CHD is responsible for around 0.4 million fatalities every year. The US has the highest consumption of healthcare devices, surgical procedures and remote monitoring of patients. According to the American Heart Association (AHA) in 2017, CVD accounts for approximately 800,000 mortalities in the US that is one out of three mortalities.

Get Sample Copy of US Cardiology Market at: https://www.omrglobal.com/request-sample/us-cardiology-market

The companies which are contributing to the growth of the US market include Abbott Laboratories, Becton, Dickinson and Co., Boston Scientific Corp, Bristol-Myers Squibb Co., Cook Medical Inc., Edwards Lifesciences Corp., and others.

The market is segmented on the basis of Device type, drug type, mechanism, and surgeries type. Based on Device type, the market is segregated angioplasty, cardiovascular stents, cardiovascular catheters, cardiac rhythm management, cardiovascular assistive devices. Angioplasty and vascular stenting are widely adopted procedures in the cardiology market and have a considerable market share. Based on the drug type, the market is segmented into antithrombotic drugs, antidyslipidemic drugs, antihypertensive drugs, and anti-stroke drugs. On the basis of surgeries type, the market is classified into coronary artery bypass grafting, transmyocardial laser revascularization, heart valve repair, arrhythmia treatment, aneurysm repair, and heart transplant. 

For More Information get A full report of US Cardiology is available at: https://www.omrglobal.com/industry-reports/us-cardiology-market

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market. 

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/us-cardiology-market

US Cardiology Market Segmentation

US Cardiology Market by Device Type 

·         Angioplasty 
·         Cardiovascular stents
·         Cardiovascular catheters
·         Cardiac rhythm management
·         Cardiovascular assistive devices

US Cardiology Market by Drug Type

·         Antithrombotic drugs
·         Antidyslipidemic drugs
·         Antihypertensive drugs
·         Anti-stroke drugs

US Cardiology Market by Mechanism

·         Beta blockers
·         Beta agonists
·         Alpha blockers
·         Alpha agonists
·         Sodium channel blockers
·         Calcium channel blockers
·         Vasodilators
·         Renin inhibitors
·         Angiotensin receptor blockers
·         Diuretics
·         Thrombolytics

US Cardiology Market by Surgeries Type

·         Coronary artery bypass grafting
·         Transmyocardial laser revascularization
·         Heart valve repair
·         Arrhythmia treatment
·         Aneurysm repair
·         Heart transplant

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

0 Comments